Tech Company Financing Transactions
MRM Health Funding Round
On 9/4/2025, MRM Health secured $64.5 million in Series B funding from Biocodex, Ackermans & Van Haaren and ATHOS Biopharma.
Transaction Overview
Company Name
Announced On
9/4/2025
Transaction Type
Venture Equity
Amount
$64,500,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to complete a Phase 2b clinical trial for its lead program MH002 in patients suffering from mild-to-moderate ulcerative colitis.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Technologiepark 73
Ghent, 9052
Belgium
Ghent, 9052
Belgium
Phone
Website
Email Address
Overview
Developing first-in-class therapeutics by harnessing the full power of the gut microbiome. For many years, microbiologists approached the concept of "mixed cultures" with caution. Scientific rigor demanded reliability and reproducibility, and the complexity of mixed microbial communities often challenged those standards. Yet, paradoxically, it is precisely these diverse microbial ecosystems--within us, around us, and throughout the planet--that drive countless essential processes impacting human health and environmental sustainability.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sam Possemiers
Browse more venture capital transactions:
Prev: 9/4/2025: YiLab Temperature Control Technologies venture capital transaction
Next: 9/4/2025: Congruence Therapeutics venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We document every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs